Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
13F holders, Q2 2026
Institutional positions in Kiora Pharmaceuticals Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +4 vs. Q1 2026
- Shares held
- 1.11M
- +766.4K (+225.9%) vs. Q1 2026
- Total value
- $2.91M
- +$2.25M (+344.1%) vs. Q1 2026
- New holders
- 10
- 3 more added
- Sold out
- 6
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.91M |
| Q1 2026 | 18 | $654.7K |
| Q4 2025 | 19 | $1.39M |
| Q3 2025 | 17 | $1.71M |
| Q2 2025 | 16 | $2.68M |
| Q1 2025 | 18 | $3.87M |
| Q4 2024 | 16 | $4.16M |
| Q3 2024 | 19 | $5.38M |
| Q2 2024 | 17 | $5.97M |
| Q1 2024 | 24 | $7.87M |
| Q4 2023 | 15 | $159.5K |
| Q3 2023 | 14 | $91.9K |
| Q2 2023 | 18 | $425.2K |
| Q1 2023 | 14 | $283.6K |
| Q4 2022 | 11 | $518.8K |
| Q3 2022 | 9 | $209.0K |
| Q2 2022 | 14 | $391.0K |
| Q1 2022 | 16 | $517.0K |
| Q4 2021 | 13 | $1.22M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Kiora Pharmaceuticals Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Activest Wealth Management | 2 | $5 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 58 | $153 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 256 | $673 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 837 | $2.20K | 0.00% | −158−15.9% | Reduced |
| Morgan Stanley | 1,408 | $3.70K | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1,813 | $4.77K | 0.00% | +1,807+30,116.7% | Added |
| UBS Group AG | 1,961 | $5.16K | 0.00% | +660+50.7% | Added |
| Jane Street Group, LLC | 10,615 | $27.9K | 0.00% | +10,615 | New |
| Northern Trust Corp | 11,767 | $30.9K | 0.00% | +11,767 | New |
| Dimensional Fund Advisors LP | 12,138 | $31.9K | 0.00% | +12,138 | New |
| LPL Financial LLC | 12,500 | $32.9K | 0.00% | +12,500 | New |
| Vanguard Fiduciary Trust Co | 13,030 | $34.3K | 0.00% | 00.0% | Unchanged |
| Scientech Research LLC | 18,746 | $49.3K | 0.04% | +18,746 | New |
| Vanguard Capital Management LLC | 19,861 | $52.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 26,717 | $70.3K | 0.00% | −21,133−44.2% | Reduced |
| Renaissance Technologies LLC | 29,824 | $78.4K | 0.00% | +29,824 | New |
| HRT Financial LP | 58,612 | $154.0K | 0.00% | +58,612 | New |
| Millennium Management LLC | 74,202 | $195.2K | 0.00% | +74,202 | New |
| Two Sigma Investments, LP | 88,792 | $233.5K | 0.00% | +88,792 | New |
| Citadel Advisors LLC | 116,011 | $305.1K | 0.00% | +66,478+134.2% | Added |
| ADAR1 Capital Management, LLC | 167,941 | $441.7K | 0.02% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 438,471 | $1.15M | 0.02% | +438,471 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,719−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,019−100.0% | Sold out |
| Rangeley Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |